Breadcrumb
The Calos Lab is focused on developing a combined gene therapy and stem cell therapy technique in order to treat Duchenne Muscular Dystrophy (DMD). DMD is a common and fatal genetic disease caused by a mutation in the dystrophin gene. We are seeking to reprogram fibroblasts from afflicted patients and correct the disease by addition of functioning dystrophin. Using a bacterial integrase known as PhiC31, we are inserting a removable reprogramming cassette and the therapeutic gene stably into the genome.



